Efficacy and Safety of Fluticasone Furoate/Vilanterol Compared With Fluticasone Propionate/Salmeterol Combination in Adult and Adolescent Patients With Persistent Asthma

@inproceedings{Woodcock2013EfficacyAS,
  title={Efficacy and Safety of Fluticasone Furoate/Vilanterol Compared With Fluticasone Propionate/Salmeterol Combination in Adult and Adolescent Patients With Persistent Asthma},
  author={Ashley Woodcock and Eugene Bleecker and Jan L{\"o}tvall and Paul Matthew O’Byrne and Eric D Bateman and Hilary V Medley and Anna Ellsworth and Loretta Jacques and William W. Busse},
  booktitle={Chest},
  year={2013}
}
BACKGROUND The combination of fluticasone furoate (FF), a novel inhaled corticosteroid (ICS), and vilanterol (VI), a long-acting β2 agonist, is under development as a once-daily treatment of asthma and COPD. The aim of this study was to compare the efficacy of FF/VI with fluticasone propionate (FP)/salmeterol (SAL) in patients with persistent asthma uncontrolled on a medium dose of ICS. METHODS In a randomized, double-blind, double-dummy, parallel group study, 806 patients received FF/VI (100… CONTINUE READING
Recent Discussions
This paper has been referenced on Twitter 13 times over the past 90 days. VIEW TWEETS

Citations

Publications citing this paper.
Showing 1-10 of 32 extracted citations

References

Publications referenced by this paper.
Showing 1-10 of 18 references

Effi cacy and optimal dosing interval of the long - acting beta 2 agonist , vilanterol , in persistent asthma : a randomised trial

  • TC Fardon, DK Lee, K Haggart, LC McFarlane, BJ Lipworth
  • Respir Med
  • 2012

Once - daily fl uticasone furoate is effi cacious in patients with symptomatic asthma on low - dose inhaled corticosteroids

  • W Busse, ER Bleecker, ED Bateman
  • Ann Allergy Asthma Immunol
  • 2012

Similar Papers

Loading similar papers…